The Report Guru

  The Microbiome Sequencing Services Market Share is projected to rise from USD 284 million in 2023 to USD 555 million by 2028, with a CAGR of 14.3%. This growth is driven by the growing demand for metagenomic sequencing, increased usage of sequencing technologies in human microbiome therapeutic development, and the high expenses linked to advanced sequencing equipment, leading to more outsourcing of these services. Nonetheless, the market's expansion may be hindered by a lack of skilled professionals for complex sample analysis. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380 Based on service, the microbiome sequencing services industry is segmented into sample preparation, sequencing and library preparation, and data analysis services. A majority of the service providers/key market players offer all three types of services as part of the microbiome analysis workflow. Variations in sample size, associated pricing, use of different te...

The global laboratory information systems market size is projected to reach USD 4.0 billion by 2028, from USD 2.4 billion in 2023, at a CAGR of 10.8% from 2023 to 2028. The growth of this market is influenced primarily due to the increasing adoption of LIS in biobanks and biorepositories, as well as the development of integrated LIS and the need to curtail escalating healthcare costs. However, high maintenance and service costs are expected to restrain the market growth during the forecast period. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232312738 The laboratory information systems (LIS) industry is witnessing several key trends that are shaping its development and future trajectory. There is a growing emphasis on interoperability and integration of LIS with other healthcare systems. Many LIS systems now offer mobile applications, allowing laboratory staff to access patient data, test results, and other information on their smart...

The preclinical imaging market is poised for significant growth in the coming years. According to the report “Preclinical Imaging Market size by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) – Global Forecast to 2029,” the market is expected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR of 5.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Dynamics and Growth Drivers The preclinical imaging market is driven by several factors. Increasing funding for preclinical research is a primary catalyst, alongside the development of cost-effective imaging systems. The rising demand for new drug development and noninvasive small-animal imaging techniques also significantly boosts the market. These factors collectively drive advancements and the adoption of preclinical ...

Human Identification Market  in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.3 billion by 2029, growing at a CAGR of 10.7% from 2024 to 2029 according to a new report by MarketsandMarkets™. In recent years, there has been substantial growth in the human identification market, driven primarily by the increasing public-private investments in the forensic science industry, and rising awareness of DNA testing technology and its application among forensic experts. Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. However, high cost of forensic tools and services may restrain the growth of human identification market during forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100607777 Browse in-depth TOC on "Human Identification Market...

The global Breast Imaging Market  in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.6 billion by 2028, growing at a CAGR of 8.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Browse in-depth TOC on “Breast Imaging Market” 244 – Tables 37 – Figures 266 – Pages Non-ionizing breast imaging technologies segment to register significant growth rate over the forecast period of 2023-2028 Based on the technology, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The non-ionizing breast imaging technologies segment is anticipated to register the highest growth rate over the forecast...

The Microbiome Sequencing Services Market  in terms of revenue was estimated to be worth $284 million in 2022 and is poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2022 to 2028 according to a new report by MarketsandMarkets™. Key driving factors of the microbiome sequencing services market growth include, expanding applications for metagenomic sequencing, high focus on development of human microbiome therapeutics, and high costs associated with sophisticated sequencing instruments. In recent years, there has been a significant increase in the demand for metagenomic sequencing in the field of microbiome research owing it its wide array of applications, such as disease diagnosis, drug discovery, and precision medicine. This is expected to boost the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380 Browse in-depth TOC on "Microbiome Sequencing Services Market" 186 - Tables 35 - Figures 200 -...

The global gene editing market size in terms of revenue, was estimated at .3 billion in 2023 and is projected to reach .6 billion by 2028, showcasing a remarkable compound annual growth rate (CAGR) of 15.0% from 2023 to 2028. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 OPPORTUNITY: Expanding pipeline for gene therapy The expanding pipeline for gene therapy in the gene editing industry presents significant opportunities for advancements in treating genetic disorders and other diseases. Gene therapy involves the delivery of therapeutic genes or gene editing tools into the patient’s cells to correct genetic mutations, restore normal gene function, or introduce therapeutic genes for targeted treatment. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and the treatment of previously incurable diseases. CHALLENGE: High equi...

The Breast Imaging Market is projected to reach USD 6.6 billion by 2028, with a CAGR of 8.5% from 2023 to 2028. The report titled "Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecasts to 2028" highlights key factors driving market growth, such as rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Technology Segment Analysis During the forecast period of 2023-2028, the non-ionizing breast imaging technologies segment is expected to experience significant growth, surpassing the ionizing breast imaging technologies segment, which held the highest market share in 2022. Product Segment Analysis In terms of product, the software & services se...

The global MIS instruments market is projected to generate $31.7 billion in revenue in 2024. This market is expected to grow at a compound annual growth rate (CAGR) of 9.5%, reaching $49.9 billion by 2029. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Key Market Segments and Insights Dominance of Handheld Instruments In 2020, the handheld instruments segment held the largest share of the MIS instruments market by product segment. The growth of this segment can be attributed to the cost-effectiveness of articulating laparoscopic handheld surgical instruments. These tools are extensively used in cardiothoracic, arthroscopy, urology, cardiovascular, and neurological surgeries. Hospitals and Specialty Clinics Lead The market is segmented by end user into hospitals and specialty clinics, and ambulatory surgery centers. In 2020, hospitals and specialty clinics dominated the market due to their substantial investments in lab automation and i...

The global gene editing market size in terms of revenue, was estimated at .3 billion in 2023 and is projected to reach .6 billion by 2028, showcasing a remarkable compound annual growth rate (CAGR) of 15.0% from 2023 to 2028. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 OPPORTUNITY: Expanding pipeline for gene therapy The expanding pipeline for gene therapy in the gene editing industry presents significant opportunities for advancements in treating genetic disorders and other diseases. Gene therapy involves the delivery of therapeutic genes or gene editing tools into the patient’s cells to correct genetic mutations, restore normal gene function, or introduce therapeutic genes for targeted treatment. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and the treatment of previously incurable diseases. CHALLENGE: High equi...

The global market for Monoclonal Antibody Therapeutics (mABs) is experiencing robust growth, driven by technological advancements, increasing prevalence of chronic diseases, and substantial investment in healthcare research and development. As CXOs, VPs, and directors navigate this dynamic landscape, understanding key market dynamics and current trends is essential for seizing emerging opportunities and overcoming challenges. Current Market Dynamics The size of the global monoclonal antibody therapeutics market was valued at approximately $252.6 billion in 2024 and is projected to reach $497.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.5% during the forecast period. This growth underscores the market's significance and potential for stakeholders across therapeutic segments including oncology, inflammatory & autoimmune diseases, and hematology. Technological advancements in production methods, particularly in-vitro and in-vivo techniques...

According to research report the report Dental Equipment Market is projected to grow from USD 6.5 billion in 2022 to USD 8.7 billion by 2027, at a compound annual growth rate (CAGR) of 6.1%. This significant growth is driven by advancements in dental technology, increasing prevalence of oral disorders, and a rising demand for cosmetic dental procedures. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 Key Market Segments Therapeutic Dental Equipment: The Fastest Growing Segment The therapeutic dental equipment segment is expected to experience the highest growth rate between 2022 and 2027. This growth is primarily driven by the introduction of advanced technologies, such as electrosurgical devices, which offer benefits like lower operating costs, minimal bleeding, and reduced post-operative pain for patients. This segment includes dental chairs, dental units, CAD/CAM systems, casting machines, and dental lasers, including Nd and carbon di...

The report Spinal Implants Market by Product (Devices: Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion; Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028 projects the market to reach USD 14.3 billion by 2028, up from USD 11.2 billion in 2023, with a CAGR of 5.0% during the forecast period. Market growth is driven by increasing demand for minimally invasive surgical procedures, rising prevalence of spinal disorders, an aging population, increased public-private investments in clinical research, and the presence of key market players in developing regions. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 Non-Fusion Devices Segment The non-fusion devices segment is expected to register significant growth from 2022 to 2028. The spinal implants market is segmented by product into thoracic fusion and lumbar fusion devices, cervica...

The global cancer biomarkers market is experiencing significant growth and is projected to reach USD 42.0 billion by 2029, up from USD 24.5 billion in 2024, with a compound annual growth rate (CAGR) of 11.3%. This surge in growth can be attributed to several key factors, including the rising prevalence of cancer worldwide, increasing use of cancer biomarkers in drug discovery and development, and ongoing research and development efforts in the field of cancer biomarkers. Emerging markets such as India and Japan also offer lucrative opportunities for market players operating in this space. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 Market Segmentation and Trends Biomarker Type The cancer biomarkers market is divided into three main segments based on biomarker type: protein, genetic, and other cancer biomarkers. In 2020, the protein biomarkers segment accounted for the largest market share, primarily due to ongoing technological advance...